ArticleFrontiers in oncology2020

Transcriptome Profiling of Acquired Gefitinib Resistant Lung Cancer Cells Reveals Dramatically Changed Transcription Programs and New Treatment Targets.

Nan Wei et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.